Fundraising Fox
Headlands Research
Lake Worth, US · Founded 2018 · Delaware corporation · 1 known investors
Find your way into Headlands Research
Sign up to see every warm intro you have to Headlands Research
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Headlands Research team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Headlands Research operates a multinational clinical trial site network that recruits and retains diverse participant populations for medical research studies. The organization supports pharmaceutical sponsors and research sites in advancing innovative therapies through operational excellence and high-quality data collection across multiple therapeutic areas.
Founders & leadership
AH
Autumn HuiattChief Financial OfficerAutumn Huiatt is an executive at Headlands Research, a clinical trial site network. She holds an MBA from the Wharton School at the University of Pennsylvania and has prior experience in financial reporting, compliance, system implementation, and mergers and acquisitions.
Board
CC
Cathy CollinsBoard director
AR
Anuv RatanBoard director
AS
Ali SatvatBoard director
DS
Dr. SherKey Opinion Leader - Immunology/Vaccine
Investors · 1
Reported raises · per SEC filings
Form D private placements$29.2M disclosed across 9 rounds · 2019–2025
▶$1.4MraisedJul 2025 · 1 investors · Other Health CareRule 506(b)
▶$1.4MraisedJul 2025 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kyle BurtnettExecutive Officer, Director
- Cathy CollinsDirector
- Anuv RatanDirector
- Ali SatvatDirector
- Ann MaoExecutive Officer
- Autumn HuiattExecutive Officer
- Offering amount
- $1.4M
- Amount sold
- $1.4M
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedNov 2024 · 1 investors · Other Health CareRule 506(b)
▶$2MraisedNov 2024 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Cathy CollinsDirector
- Autumn HuiattExecutive Officer
- Ann MaoExecutive Officer
- Ali SatvatDirector
- Anuv RatanDirector
- Kyle BurtnettExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$250KraisedMar 2024 · 1 investors · Other Health CareRule 506(b)
▶$250KraisedMar 2024 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ann MaoExecutive Officer
- Anuv RatanDirector
- Kyle BurtnettExecutive Officer, Director
- Autumn HuiattExecutive Officer
- Cathy CollinsDirector
- Ali SatvatDirector
- Offering amount
- $250K
- Amount sold
- $250K
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedOct 2023 · 2 investors · Other Health CareRule 506(b)
▶$10MraisedOct 2023 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kyle BurtnettExecutive Officer
- Ali SatvatDirector
- Kathy CollinsDirector
- Anuv RatanDirector
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$1.4MraisedMay 2023 · 1 investors · Other Health CareRule 506(b)
▶$1.4MraisedMay 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ali SatvatDirector
- Anuv RatanDirector
- Cathy CollinsExecutive Officer, Director
- Offering amount
- $1.4M
- Amount sold
- $1.4M
- First sale
- May 2023
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$2.9MraisedMay 2022 · 1 investors · Other Health CareRule 506(b)
▶$2.9MraisedMay 2022 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Heather AbbisDirector
- Cathy CollinsDirector
- Mark BlumlingExecutive Officer, Director
- Ali SatvatDirector
- Anuv RatanDirector
- Offering amount
- $2.9M
- Amount sold
- $2.9M
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$1.2MraisedApr 2021 · 1 investors · Other Health CareRule 506(b)
▶$1.2MraisedApr 2021 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ali SatvatDirector
- Cathy CollinsDirector
- Anuv RatanDirector
- Mark BlumlingExecutive Officer, Director
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$1MraisedApr 2021 · 1 investors · Other Health CareRule 506(b)
▶$1MraisedApr 2021 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ali SatvatDirector
- Cathy CollinsDirector
- Anuv RatanDirector
- Mark BlumlingExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
VeevaVeeva Clinical Platform is a cloud-based suite of connected applications for running clinical trials, covering clinical operations, clinical data, research sites, and patients. It serves biopharma sponsors, clinical research sites, and patients across trial management, data capture, and disclosures.
PowerPower builds a patient-friendly platform to discover and enroll in clinical trials, serving patients seeking access to research studies and researchers seeking to improve patient recruitment. The company operates in the healthcare technology and clinical research industry.
MD Anderson Cancer CenterUT MD Anderson is a cancer research and treatment center that provides patient care, conducts research, and offers education in cancer prevention and treatment. It is part of the University of Texas System and operates as a nonprofit medical institution.
Companies working in the same space as Headlands Research.
In the news
Frequently asked questions
- What does Headlands Research do?
- Headlands Research operates a multinational clinical trial site network that recruits and retains diverse participant populations for medical research studies. The organization supports pharmaceutical sponsors and research sites in advancing innovative therapies through operational excellence and high-quality data collection across multiple therapeutic areas.
- Who are Headlands Research's investors?
- Headlands Research's investors include THL FUND.
- How much funding has Headlands Research raised?
- Headlands Research has disclosed $29.2M raised across 9 rounds.
- Where is Headlands Research headquartered?
- Headlands Research is headquartered in Lake Worth, US.